Literature DB >> 28664773

The role of cardiac rehabilitation in secondary prevention after coronary events.

Kari Peersen1,2, John Munkhaugen3, Lars Gullestad2,4, Toril Liodden1, Torbjorn Moum5, Toril Dammen5, Joep Perk6, Jan E Otterstad1.   

Abstract

Background Coronary risk factor control in Europe is suboptimal and there are large variations in the nature of cardiac rehabilitation (CR) programmes offered to coronary heart disease patients. We aim to explore characteristics and risk factor control in patients recruited from two neighbouring hospitals offering CR with different content. Methods In a cross-sectional study, 1127 Norwegian patients hospitalized with acute myocardial infarction and/or a revascularization procedure attended a clinical visit and completed a questionnaire at 2-36 months' follow-up. The hospital of Vestfold provides comprehensive CR, while the hospital of Drammen provides mainly exercise-based CR. Results At follow-up, patients in Vestfold performed more physical activity ( p = 0.02), were less obese ( p = 0.02) and reported better medication adherence ( p = 0.02) than patients in Drammen. The perceived need for information and follow-up was higher in Drammen than Vestfold ( p < 0.001). The CR participation rate in Vestfold was 75% compared with 18% in Drammen. CR participation in Vestfold was associated with higher prevalence of smoking cessation ( p = 0.001), lower low-density lipoprotein cholesterol ( p = 0.01) and better medication adherence ( p = 0.02) compared with non-CR, in adjusted analyses. No differences in diet, body weight, or blood pressure control were found between CR and non-CR. Conclusions Vestfold, with comprehensive CR, had a higher participation rate and more risk factors on target than Drammen. Participation in CR in Vestfold was associated with higher levels of smoking cessation and medication adherence, and lower low-density lipoprotein cholesterol, but overall risk factor control is still deficient, underlining the need for improved understanding of barriers to optimal risk factor control.

Entities:  

Keywords:  Secondary prevention; cardiac rehabilitation; coronary heart disease patients; drug adherence; information; lifestyle changes; risk factor control

Mesh:

Year:  2017        PMID: 28664773     DOI: 10.1177/2047487317719355

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  10 in total

Review 1.  Recent Approaches to Improve Medication Adherence in Patients with Coronary Heart Disease: Progress Towards a Learning Healthcare System.

Authors:  Andrew E Levy; Carrie Huang; Allen Huang; P Michael Ho
Journal:  Curr Atheroscler Rep       Date:  2018-01-24       Impact factor: 5.113

2.  Patient Perception of How Smoking Status Influences Cardiac Rehabilitation Attendance After an Acute Cardiac Hospitalization.

Authors:  Hayden Riley; Samuel Headley; Peter K Lindenauer; Sarah Goff; Heidi Szalai; Diann E Gaalema; Quinn R Pack
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-05       Impact factor: 2.081

3.  Protein Intake and Physical Activity in Newly Diagnosed Patients with Acute Coronary Syndrome: A 5-Year Longitudinal Study.

Authors:  Andrea Greco; Agostino Brugnera; Roberta Adorni; Marco D'Addario; Francesco Fattirolli; Cristina Franzelli; Cristina Giannattasio; Alessandro Maloberti; Francesco Zanatta; Patrizia Steca
Journal:  Nutrients       Date:  2021-02-16       Impact factor: 5.717

4.  Effects of Leisure-Time and Transport-Related Physical Activities on the Risk of Incident and Recurrent Myocardial Infarction and Interaction With Traffic-Related Air Pollution: A Cohort Study.

Authors:  Nadine J Kubesch; Jeanette Therming Jørgensen; Barbara Hoffmann; Steffen Loft; Mark J Nieuwenhuijsen; Ole Raaschou-Nielsen; Marie Pedersen; Ole Hertel; Kim Overvad; Anne Tjønneland; Eva Prescot; Zorana J Andersen
Journal:  J Am Heart Assoc       Date:  2018-07-18       Impact factor: 5.501

5.  Additional effects of psychological interventions on subjective and objective outcomes compared with exercise-based cardiac rehabilitation alone in patients with cardiovascular disease: A systematic review and meta-analysis.

Authors:  Christian Albus; Christoph Herrmann-Lingen; Katrin Jensen; Matthes Hackbusch; Nina Münch; Catharina Kuncewicz; Maurizio Grilli; Bernhard Schwaab; Bernhard Rauch
Journal:  Eur J Prev Cardiol       Date:  2019-03-11       Impact factor: 7.804

6.  Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population.

Authors:  E Sverre; K Peersen; H Weedon-Fekjær; J Perk; E Gjertsen; E Husebye; L Gullestad; T Dammen; J E Otterstad; J Munkhaugen
Journal:  BMC Cardiovasc Disord       Date:  2020-02-05       Impact factor: 2.298

7.  Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial.

Authors:  Anete Kaldal; Serena Tonstad; Jarle Jortveit
Journal:  BMC Cardiovasc Disord       Date:  2021-12-16       Impact factor: 2.298

8.  Frailty Test Battery Development including Physical, Socio-Psychological and Cognitive Domains for Cardiovascular Disease Patients: A Preliminary Study.

Authors:  Nastasia Marinus; Carlo Vigorito; Francesco Giallauria; Paul Dendale; Raf Meesen; Kevin Bokken; Laura Haenen; Thomas Jansegers; Yenthe Vandenheuvel; Martijn Scherrenberg; Joke Spildooren; Dominique Hansen
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

9.  Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.

Authors:  John Munkhaugen; Jøran Hjelmesæth; Jan Erik Otterstad; Ragnhild Helseth; Stina Therese Sollid; Erik Gjertsen; Lars Gullestad; Joep Perk; Torbjørn Moum; Einar Husebye; Toril Dammen
Journal:  BMC Cardiovasc Disord       Date:  2018-08-03       Impact factor: 2.298

10.  Prognostic impact of non-improvement of global longitudinal strain in patients with revascularized acute myocardial infarction.

Authors:  Jan Erik Otterstad; Ingvild Billehaug Norum; Vidar Ruddox; An Chau Maria Le; Bjørn Bendz; John Munkhaugen; Ole Klungsøyr; Thor Edvardsen
Journal:  Int J Cardiovasc Imaging       Date:  2021-07-29       Impact factor: 2.357

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.